Evidence map›Paper›PMID 38609903›Full record

ArticleBMC public health2024

Estimated public health impact of concurrent mask mandate and vaccinate-or-test requirement in Illinois, October to December 2021.

François M Castonguay, Arti Barnes, Seonghye Jeon, Jane Fornoff, Bishwa B Adhikari, Leah S Fischer, Bradford Greening, Adebola O Hassan, Emily B Kahn, Gloria J Kang and 4 more

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

François M CastonguayNational Center for Emerging and Zoonotic Infectious Diseases, Division of Preparedness and Emerging Infections, Centers for Disease Control and Prevention, Health Economics and Modeling Unit, U.S. Department of Health and Human Services, 7101 Avenue du Parc, Local 3180, QC H3N 1X9, Atlanta, Georgia. francois.castonguay@umontreal.ca.
Arti BarnesIllinois Department of Public Health, Springfield, IL, USA.
Seonghye JeonNational Center for Emerging and Zoonotic Infectious Diseases, Division of Preparedness and Emerging Infections, Centers for Disease Control and Prevention, Health Economics and Modeling Unit, U.S. Department of Health and Human Services, 7101 Avenue du Parc, Local 3180, QC H3N 1X9, Atlanta, Georgia.
Jane FornoffIllinois Department of Public Health, Springfield, IL, USA.
Bishwa B AdhikariNational Center for Emerging and Zoonotic Infectious Diseases, Division of Preparedness and Emerging Infections, Centers for Disease Control and Prevention, Health Economics and Modeling Unit, U.S. Department of Health and Human Services, 7101 Avenue du Parc, Local 3180, QC H3N 1X9, Atlanta, Georgia.
Leah S FischerNational Center for Emerging and Zoonotic Infectious Diseases, Division of Preparedness and Emerging Infections, Centers for Disease Control and Prevention, Health Economics and Modeling Unit, U.S. Department of Health and Human Services, 7101 Avenue du Parc, Local 3180, QC H3N 1X9, Atlanta, Georgia.
Bradford GreeningNational Center for Emerging and Zoonotic Infectious Diseases, Division of Preparedness and Emerging Infections, Centers for Disease Control and Prevention, Health Economics and Modeling Unit, U.S. Department of Health and Human Services, 7101 Avenue du Parc, Local 3180, QC H3N 1X9, Atlanta, Georgia.
Adebola O HassanIllinois Department of Public Health, Springfield, IL, USA.
Emily B KahnNational Center for Emerging and Zoonotic Infectious Diseases, Division of Preparedness and Emerging Infections, Centers for Disease Control and Prevention, Health Economics and Modeling Unit, U.S. Department of Health and Human Services, 7101 Avenue du Parc, Local 3180, QC H3N 1X9, Atlanta, Georgia.
Gloria J KangNational Center for Emerging and Zoonotic Infectious Diseases, Division of Preparedness and Emerging Infections, Centers for Disease Control and Prevention, Health Economics and Modeling Unit, U.S. Department of Health and Human Services, 7101 Avenue du Parc, Local 3180, QC H3N 1X9, Atlanta, Georgia.
Judy KaueraufIllinois Department of Public Health, Springfield, IL, USA.
Sarah PatrickIllinois Department of Public Health, Springfield, IL, USA.
Sameer VohraIllinois Department of Public Health, Springfield, IL, USA.
Martin I MeltzerNational Center for Emerging and Zoonotic Infectious Diseases, Division of Preparedness and Emerging Infections, Centers for Disease Control and Prevention, Health Economics and Modeling Unit, U.S. Department of Health and Human Services, 7101 Avenue du Parc, Local 3180, QC H3N 1X9, Atlanta, Georgia.
Illinois Department of Public Health · USCenters for Disease Control and Prevention · USOffice of Tribal Affairs and Strategic Alliances · USNational Center for Emerging and Zoonotic Infectious Diseases · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFacing a surge of COVID-19 cases in late August 2021, the U.S. state of Illinois re-enacted its COVID-19 mask mandate for the general public and issued a requirement for workers in certain professions to be vaccinated against COVID-19 or undergo weekly testing. The mask mandate required any individual, regardless of their vaccination status, to wear a well-fitting mask in an indoor setting.

methodsWe used Illinois Department of Public Health's COVID-19 confirmed case and vaccination data and investigated scenarios where masking and vaccination would have been reduced to mimic what would have happened had the mask mandate or vaccine requirement not been put in place. The study examined a range of potential reductions in masking and vaccination mimicking potential scenarios had the mask mandate or vaccine requirement not been enacted. We estimated COVID-19 cases and hospitalizations averted by changes in masking and vaccination during the period covering October 20 to December 20, 2021.

resultsWe find that the announcement and implementation of a mask mandate are likely to correlate with a strong protective effect at reducing COVID-19 burden and the announcement of a vaccinate-or-test requirement among frontline professionals is likely to correlate with a more modest protective effect at reducing COVID-19 burden. In our most conservative scenario, we estimated that from the period of October 20 to December 20, 2021, the mask mandate likely prevented approximately 58,000 cases and 1,175 hospitalizations, while the vaccinate-or-test requirement may have prevented at most approximately 24,000 cases and 475 hospitalizations.

conclusionOur results indicate that mask mandates and vaccine-or-test requirements are vital in mitigating the burden of COVID-19 during surges of the virus.

Indexed as

COVID-19VaccinesHumansIllinoisPublic HealthVaccinationVaccinesCases and hospitalizations avertedCOVID-19MasksModelingVaccines

Identifiers

PMID38609903
PMCPMC11010411
OpenAlexW4394757118

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.